|
| General Information | |||
|---|---|---|---|
| Term | variant ABeta2M amyloidosis | ID (Ontology) | DOID:0080929 (Human Disease) |
| Definition | An amyloidosis that is characterized by accumulation and extensive visceral deposition of anamyloidogenic variant of beta 2 microglobulin leading to progressive gastrointestinal dysfunction, Sjögren syndrome and autonomic neuropathy. | ||
| Also Known As | "Autosomal dominant beta2-microglobulinic amyloidosis" | ||
| Comment | |||
| Links to External Ontologies | |||
| DO.org | |||
| Annotations | |||
| Records annotated with this term OR any of its CHILD TERMS | |||
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
|||
|
No relevant statements available
|
|||
|
||||||
disease of metabolism |__inherited metabolic disorder__ |__amyloidosis___________________| autosomal genetic disease | |__autosomal dominant disease____| genetic disease | |__inherited metabolic disorder__| variant ABeta2M amyloidosis |
| Spanning Tree View Settings | |||
|---|---|---|---|
| Parents/Children View Depth |
|||
Relationships
|
|||
| Is a |
autosomal dominant disease inherited metabolic disorder amyloidosis |
||
| Part of | |||
|
Synonyms & Secondary IDs
|
|||
| Synonyms | |||
|
|||
| Secondary IDs | |||
|
|
|||
|
External Crossreferences & Linkouts
|
|||
| ORDO:314652 | |||